BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Freedman BI, Limou S, Ma L, Kopp JB. APOL1-Associated Nephropathy: A Key Contributor to Racial Disparities in CKD. Am J Kidney Dis 2018;72:S8-S16. [PMID: 30343724 DOI: 10.1053/j.ajkd.2018.06.020] [Cited by in Crossref: 53] [Cited by in F6Publishing: 42] [Article Influence: 17.7] [Reference Citation Analysis]
Number Citing Articles
1 Hamroun A, Frimat M, Beuscart JB, Buob D, Lionet A, Lebas C, Daroux M, Provôt F, Hazzan M, Boulanger É, Glowacki F. [Kidney disease care for the elderly]. Nephrol Ther 2019;15:533-52. [PMID: 31711751 DOI: 10.1016/j.nephro.2019.10.001] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
2 Hong M, Ebana Y, Shim J, Choi EK, Lim HE, Hwang I, Yu HT, Kim TH, Uhm JS, Joung B, Oh S, Lee MH, Kim YH, Jee SH, Pak HN. Ethnic similarities in genetic polymorphisms associated with atrial fibrillation: Far East Asian vs European populations. Eur J Clin Invest 2021;51:e13584. [PMID: 33990960 DOI: 10.1111/eci.13584] [Reference Citation Analysis]
3 Luyckx VA, Rule AD, Tuttle KR, Delanaye P, Liapis H, Gandjour A, Romagnani P, Anders HJ. Nephron overload as a therapeutic target to maximize kidney lifespan. Nat Rev Nephrol 2021. [PMID: 34880459 DOI: 10.1038/s41581-021-00510-7] [Reference Citation Analysis]
4 Forster BM, Nee R, Little DJ, Greasley PJ, Hughes JB, Gordon SM, Olson SW. Focal Segmental Glomerulosclerosis, Risk Factors for End Stage Kidney Disease, and Response to Immunosuppression. Kidney360 2021;2:105-13. [DOI: 10.34067/kid.0006172020] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
5 Alfano G, Cappelli G, Fontana F, Di Lullo L, Di Iorio B, Bellasi A, Guaraldi G. Kidney Disease in HIV Infection. J Clin Med 2019;8:E1254. [PMID: 31430930 DOI: 10.3390/jcm8081254] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
6 Murray SL, Fennelly NK, Doyle B, Lynch SA, Conlon PJ. Integration of genetic and histopathology data in interpretation of kidney disease. Nephrol Dial Transplant 2020;35:1113-32. [PMID: 32777081 DOI: 10.1093/ndt/gfaa176] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
7 Ge M, Molina J, Ducasa GM, Mallela SK, Varona Santos J, Mitrofanova A, Kim JJ, Liu X, Sloan A, Mendez AJ, Banerjee S, Liu S, Szeto HH, Shin MK, Hoek M, Kopp JB, Fontanesi F, Merscher S, Fornoni A. APOL1 risk variants affect podocyte lipid homeostasis and energy production in focal segmental glomerulosclerosis. Hum Mol Genet 2021;30:182-97. [PMID: 33517446 DOI: 10.1093/hmg/ddab022] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Freedman BI, Moxey-Mims MM, Alexander AA, Astor BC, Birdwell KA, Bowden DW, Bowen G, Bromberg J, Craven TE, Dadhania DM, Divers J, Doshi MD, Eidbo E, Fornoni A, Gautreaux MD, Gbadegesin RA, Gee PO, Guerra G, Hsu CY, Iltis AS, Jefferson N, Julian BA, Klassen DK, Koty PP, Langefeld CD, Lentine KL, Ma L, Mannon RB, Menon MC, Mohan S, Moore JB, Murphy B, Newell KA, Odim J, Ortigosa-Goggins M, Palmer ND, Park M, Parsa A, Pastan SO, Poggio ED, Rajapakse N, Reeves-Daniel AM, Rosas SE, Russell LP, Sawinski D, Smith SC, Spainhour M, Stratta RJ, Weir MR, Reboussin DM, Kimmel PL, Brennan DC. APOL1 Long-term Kidney Transplantation Outcomes Network (APOLLO): Design and Rationale. Kidney Int Rep 2020;5:278-88. [PMID: 32154449 DOI: 10.1016/j.ekir.2019.11.022] [Cited by in Crossref: 22] [Cited by in F6Publishing: 15] [Article Influence: 7.3] [Reference Citation Analysis]
9 Devuyst O, Olinger E, Weber S, Eckardt K, Kmoch S, Rampoldi L, Bleyer AJ. Autosomal dominant tubulointerstitial kidney disease. Nat Rev Dis Primers 2019;5. [DOI: 10.1038/s41572-019-0109-9] [Cited by in Crossref: 35] [Cited by in F6Publishing: 34] [Article Influence: 11.7] [Reference Citation Analysis]
10 Olawoye O, Chuka-Okosa C, Akpa O, Realini T, Hauser M, Ashaye A. Eyes of Africa: The Genetics of Blindness: Study Design and Methodology. BMC Ophthalmol 2021;21:272. [PMID: 34243759 DOI: 10.1186/s12886-021-02029-8] [Reference Citation Analysis]
11 Atutornu J, Milne R, Costa A, Patch C, Middleton A. Towards equitable and trustworthy genomics research. EBioMedicine 2022;76:103879. [PMID: 35158310 DOI: 10.1016/j.ebiom.2022.103879] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
12 Iorember FM, Bamgbola OF. Structural Inequities and Barriers to Accessing Kidney Healthcare Services in the United States: A Focus on Uninsured and Undocumented Children and Young Adults. Front Pediatr 2022;10:833611. [DOI: 10.3389/fped.2022.833611] [Reference Citation Analysis]
13 Johnson SB, Slade I, Giubilini A, Graham M. Rethinking the ethical principles of genomic medicine services. Eur J Hum Genet 2020;28:147-54. [PMID: 31534213 DOI: 10.1038/s41431-019-0507-1] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 4.3] [Reference Citation Analysis]
14 Gopalakrishnan C, Patorno E. Time to end the misuse of race in medicine: cases from nephrology. BMJ 2021;375:n2435. [PMID: 34667058 DOI: 10.1136/bmj.n2435] [Reference Citation Analysis]
15 Freedman BI, Kopp JB, Sampson MG, Susztak K. APOL1 at 10 years: progress and next steps. Kidney Int 2021;99:1296-302. [PMID: 33794228 DOI: 10.1016/j.kint.2021.03.013] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
16 Lyas C. It’s Not All Even. Physician Assistant Clinics 2022;7:357-65. [DOI: 10.1016/j.cpha.2021.11.006] [Reference Citation Analysis]
17 Kumar RN, Stosor V. Organ transplantation in persons with HIV. AIDS 2020;34:1107-16. [PMID: 32167973 DOI: 10.1097/QAD.0000000000002518] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
18 Laster M, Shen JI, Norris KC. Kidney Disease Among African Americans: A Population Perspective. Am J Kidney Dis 2018;72:S3-7. [PMID: 30343720 DOI: 10.1053/j.ajkd.2018.06.021] [Cited by in Crossref: 24] [Cited by in F6Publishing: 19] [Article Influence: 8.0] [Reference Citation Analysis]
19 Panico C, Thompson A. African Americans, Kidney Disease, and Drug Development: A Regulatory Perspective. Am J Kidney Dis 2018;72:S33-6. [PMID: 30343721 DOI: 10.1053/j.ajkd.2018.06.023] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
20 Bird KA. No support for the hereditarian hypothesis of the Black-White achievement gap using polygenic scores and tests for divergent selection. Am J Phys Anthropol 2021;175:465-76. [PMID: 33529393 DOI: 10.1002/ajpa.24216] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
21 Davidson A, Aranow C, Mackay M. Lupus nephritis: challenges and progress. Curr Opin Rheumatol 2019;31:682-8. [PMID: 31389814 DOI: 10.1097/BOR.0000000000000642] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
22 Krissberg JR, Helmuth ME, Almaani S, Cai Y, Cattran D, Chatterjee D, Gbadegesin RA, Gibson KL, Glenn DA, Greenbaum LA, Iragorri S, Jain K, Khalid M, Kidd JM, Kopp JB, Lafayette R, Nestor JG, Parekh RS, Reidy KJ, David T Selewski, John Sperati C, Tuttle KR, Twombley K, Vasylyeva TL, Weaver DJ Jr, Wenderfer SE, O'Shaughnessy MM. Racial-ethnic differences in health-related quality of life among adults and children with glomerular disease. Glomerular Dis 2021;1:105-17. [PMID: 34723246 DOI: 10.1159/000516832] [Reference Citation Analysis]
23 Gupta N, Wang X, Wen X, Moran P, Paluch M, Hass PE, Heidersbach A, Haley B, Kirchhofer D, Brezski RJ, Peterson AS, Scales SJ. Domain-Specific Antibodies Reveal Differences in the Membrane Topologies of Apolipoprotein L1 in Serum and Podocytes. J Am Soc Nephrol 2020;31:2065-82. [PMID: 32764138 DOI: 10.1681/ASN.2019080830] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
24 Freedman BI, Poggio ED. APOL1 genotyping in kidney transplantation: to do or not to do, that is the question? (pro). Kidney Int 2021;100:27-30. [PMID: 34154719 DOI: 10.1016/j.kint.2020.11.025] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
25 Kaboré NF, Limou S. Balancing the genetic risk of APOL1 kidney disease variants. Nephrol Ther 2019;15 Suppl 1:S79-84. [PMID: 30981400 DOI: 10.1016/j.nephro.2019.03.007] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
26 Friedman DJ, Pollak MR. APOL1 Nephropathy: From Genetics to Clinical Applications. Clin J Am Soc Nephrol 2021;16:294-303. [PMID: 32616495 DOI: 10.2215/CJN.15161219] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 5.5] [Reference Citation Analysis]
27 Ahmed S, Nutt CT, Eneanya ND, Reese PP, Sivashanker K, Morse M, Sequist T, Mendu ML. Examining the Potential Impact of Race Multiplier Utilization in Estimated Glomerular Filtration Rate Calculation on African-American Care Outcomes. J Gen Intern Med 2021;36:464-71. [PMID: 33063202 DOI: 10.1007/s11606-020-06280-5] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 9.0] [Reference Citation Analysis]
28 Adeyemo AA, Shriner D, Bentley AR, Gbadegesin RA, Rotimi CN. Evolutionary genetics and acclimatization in nephrology. Nat Rev Nephrol 2021;17:827-39. [PMID: 34584272 DOI: 10.1038/s41581-021-00483-7] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
29 Sun Y, Cui S, Hou Y, Yi F. The Updates of Podocyte Lipid Metabolism in Proteinuric Kidney Disease. Kidney Dis (Basel) 2021;7:438-51. [PMID: 34901191 DOI: 10.1159/000518132] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
30 Muehlig AK, Gies S, Huber TB, Braun F. Collapsing Focal Segmental Glomerulosclerosis in Viral Infections. Front Immunol 2021;12:800074. [PMID: 35095882 DOI: 10.3389/fimmu.2021.800074] [Cited by in Crossref: 5] [Cited by in F6Publishing: 2] [Article Influence: 5.0] [Reference Citation Analysis]
31 Iltis AS, Connell A, Cooper L, Gee PO, Jefferson NM, Johnson HA, Kingston GM, Roberts GV, Scott N, Smith A, Waddy S, Woodard L, DuBois JM. Improving Kidney Disease Research in the Black Community: The Essential Role of Black Voices in the APOLLO Study. Am J Kidney Dis 2021:S0272-6386(21)00916-1. [PMID: 34653538 DOI: 10.1053/j.ajkd.2021.09.006] [Reference Citation Analysis]
32 Harer MW, Charlton JR, Tipple TE, Reidy KJ. Preterm birth and neonatal acute kidney injury: implications on adolescent and adult outcomes. J Perinatol 2020;40:1286-95. [DOI: 10.1038/s41372-020-0656-7] [Cited by in Crossref: 9] [Cited by in F6Publishing: 4] [Article Influence: 4.5] [Reference Citation Analysis]
33 Mohan S, Iltis AS, Sawinski D, DuBois JM. APOL1 Genetic Testing in Living Kidney Transplant Donors. Am J Kidney Dis 2019;74:538-43. [PMID: 30982552 DOI: 10.1053/j.ajkd.2019.02.007] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 4.7] [Reference Citation Analysis]
34 Yuan Q, Tang B, Zhang C. Signaling pathways of chronic kidney diseases, implications for therapeutics. Signal Transduct Target Ther 2022;7:182. [PMID: 35680856 DOI: 10.1038/s41392-022-01036-5] [Reference Citation Analysis]
35 Owen KA, Grammer AC, Lipsky PE. Deconvoluting the heterogeneity of SLE: The contribution of ancestry. J Allergy Clin Immunol 2021:S0091-6749(21)01762-0. [PMID: 34857396 DOI: 10.1016/j.jaci.2021.11.005] [Reference Citation Analysis]
36 Freedman BI, Larsen CP. Apolipoprotein L1 Gene Testing Comes of Age. Kidney360 2020;1:58-61. [DOI: 10.34067/kid.0000162019] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
37 Harris DD, Fleishman A, Pavlakis M, Pollak MR, Baliga PK, Rohan V, Kayler LK, Rodrigue JR. Apolipoprotein L1 Opinions of African American Living Kidney Donors, Kidney Transplant Patients, and Nonpatients. J Surg Res 2022;277:116-24. [PMID: 35489216 DOI: 10.1016/j.jss.2022.04.011] [Reference Citation Analysis]
38 Friedman DJ, Ma L, Freedman BI. Treatment potential in APOL1-associated nephropathy. Current Opinion in Nephrology & Hypertension 2022;31:442-8. [DOI: 10.1097/mnh.0000000000000816] [Reference Citation Analysis]
39 Jacobs-Cachá C, Vergara A, García-Carro C, Agraz I, Toapanta-Gaibor N, Ariceta G, Moreso F, Serón D, López-Hellín J, Soler MJ. Challenges in primary focal segmental glomerulosclerosis diagnosis: from the diagnostic algorithm to novel biomarkers. Clin Kidney J 2021;14:482-91. [PMID: 33623672 DOI: 10.1093/ckj/sfaa110] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
40 Moxey-Mims M. Kidney Disease in African American Children: Biological and Nonbiological Disparities. Am J Kidney Dis 2018;72:S17-21. [PMID: 30343717 DOI: 10.1053/j.ajkd.2018.06.025] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 2.7] [Reference Citation Analysis]
41 Chen S, Kowalewska J, Mccune TR. COVID-19 Associated Collapsing FSGS in an APOL1 Homozygous Transplant Recipient After Successful COVID Vaccination: A Case Report. Transplantation Proceedings 2021. [DOI: 10.1016/j.transproceed.2021.11.001] [Reference Citation Analysis]
42 Kovesdy CP. CKD in African Americans as a Complex Intertwining of Biology and Socioeconomics: An Introduction. American Journal of Kidney Diseases 2018;72:S1-2. [DOI: 10.1053/j.ajkd.2018.06.019] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
43 Divers J, Ma L, Brown WM, Palmer ND, Choi Y, Israni AK, Pastan SO, Julian BA, Gaston RS, Hicks PJ, Reeves-Daniel AM, Freedman BI. Genome-wide association study for time to failure of kidney transplants from African American deceased donors. Clin Transplant 2020;34:e13827. [PMID: 32080893 DOI: 10.1111/ctr.13827] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
44 Freedman BI, Mena-Gutierrez AM, Ma L. Recipient APOL1 Genotype Effects on Outcomes After Kidney Transplantation. Am J Kidney Dis 2021:S0272-6386(21)00995-1. [PMID: 34801598 DOI: 10.1053/j.ajkd.2021.11.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
45 Bentley AR, Callier SL, Rotimi CN. Evaluating the promise of inclusion of African ancestry populations in genomics. NPJ Genom Med 2020;5:5. [PMID: 32140257 DOI: 10.1038/s41525-019-0111-x] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 11.5] [Reference Citation Analysis]
46 Cutrim ÉMM, Neves PDMDM, Campos MAG, Wanderley DC, Teixeira-júnior AAL, Muniz MPR, Ladchumananandasivam FR, Gomes OV, Vasco RFV, Brito DJDA, Lages JS, Salgado-filho N, Guedes FL, de Almeida JB, Magalhães M, Araújo SDA, Silva GEB. Collapsing Glomerulopathy: A Review by the Collapsing Brazilian Consortium. Front Med 2022;9:846173. [DOI: 10.3389/fmed.2022.846173] [Reference Citation Analysis]
47 Williams SM, Sirugo G, Tishkoff SA. Embracing African Genetic Diversity. Med 2021;2:19-20. [DOI: 10.1016/j.medj.2020.12.019] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
48 Ando M, Ando Y. A high likelihood of increase in end-stage renal disease among the Japanese HIV-infected population. Ren Replace Ther 2019;5. [DOI: 10.1186/s41100-019-0245-4] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
49 Heron JE, Bagnis CI, Gracey DM. Contemporary issues and new challenges in chronic kidney disease amongst people living with HIV. AIDS Res Ther 2020;17:11. [PMID: 32178687 DOI: 10.1186/s12981-020-00266-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
50 Chen TK, Surapaneni AL, Arking DE, Ballantyne CM, Boerwinkle E, Chen J, Coresh J, Köttgen A, Susztak K, Tin A, Yu B, Grams ME. APOL1 Kidney Risk Variants and Proteomics. Clin J Am Soc Nephrol 2022;17:684-92. [PMID: 35474272 DOI: 10.2215/CJN.14701121] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
51 Daneshpajouhnejad P, Kopp JB, Winkler CA, Rosenberg AZ. The evolving story of apolipoprotein L1 nephropathy: the end of the beginning. Nat Rev Nephrol 2022. [PMID: 35217848 DOI: 10.1038/s41581-022-00538-3] [Reference Citation Analysis]
52 Bien SA, Wojcik GL, Hodonsky CJ, Gignoux CR, Cheng I, Matise TC, Peters U, Kenny EE, North KE. The Future of Genomic Studies Must Be Globally Representative: Perspectives from PAGE. Annu Rev Genomics Hum Genet 2019;20:181-200. [PMID: 30978304 DOI: 10.1146/annurev-genom-091416-035517] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 3.7] [Reference Citation Analysis]
53 Opazo-Ríos L, Mas S, Marín-Royo G, Mezzano S, Gómez-Guerrero C, Moreno JA, Egido J. Lipotoxicity and Diabetic Nephropathy: Novel Mechanistic Insights and Therapeutic Opportunities. Int J Mol Sci 2020;21:E2632. [PMID: 32290082 DOI: 10.3390/ijms21072632] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 11.5] [Reference Citation Analysis]
54 Duran CE, Ramírez A, Posada JG, Schweineberg J, Mesa L, Pachajoa H, Estacio M, Manzi E, Aros V, Díaz L, Garcia VH. Prevalence of APOL1 Risk Variants in Afro-Descendant Patients with Chronic Kidney Disease in a Latin American Country. Int J Nephrol 2019;2019:7076326. [PMID: 31929905 DOI: 10.1155/2019/7076326] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
55 Ross MJ. New Insights into APOL1 and Kidney Disease in African Children and Brazilians Living With End-Stage Kidney Disease. Kidney Int Rep 2019;4:908-10. [PMID: 31317110 DOI: 10.1016/j.ekir.2019.04.015] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
56 Tedla FM, Yap E. Apolipoprotein L1 and kidney transplantation. Curr Opin Organ Transplant 2019;24:97-102. [PMID: 30507707 DOI: 10.1097/MOT.0000000000000600] [Cited by in Crossref: 3] [Article Influence: 0.8] [Reference Citation Analysis]
57 Sirugo G, Williams SM, Tishkoff SA. The Missing Diversity in Human Genetic Studies. Cell 2019;177:1080. [PMID: 31051100 DOI: 10.1016/j.cell.2019.04.032] [Cited by in Crossref: 51] [Cited by in F6Publishing: 35] [Article Influence: 17.0] [Reference Citation Analysis]
58 Gordon EJ, Amórtegui D, Blancas I, Wicklund C, Friedewald J, Sharp RR. A Focus Group Study on African American Living Donors’ Treatment Preferences, Sociocultural Factors, and Health Beliefs About Apolipoprotein L1 Genetic Testing. Prog Transpl 2019;29:239-47. [DOI: 10.1177/1526924819854485] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
59 Malone AF. APOL1 risk variants in kidney transplantation: a modulation of immune cell function. J Clin Invest 2021;131:e154676. [PMID: 34779415 DOI: 10.1172/JCI154676] [Reference Citation Analysis]
60 Mir SA, Biswas N, Cheung W, Wan J, Webster N, Macedo E, O'Connor DT, Vaingankar SM. Chromogranin A pathway: from pathogenic molecule to renal disease. J Hypertens 2020;38:456-66. [PMID: 31714338 DOI: 10.1097/HJH.0000000000002295] [Reference Citation Analysis]
61 Sirugo G, Williams SM, Tishkoff SA. The Missing Diversity in Human Genetic Studies. Cell 2019;177:26-31. [PMID: 30901543 DOI: 10.1016/j.cell.2019.02.048] [Cited by in Crossref: 253] [Cited by in F6Publishing: 205] [Article Influence: 126.5] [Reference Citation Analysis]
62 Freedman BI, Burke W, Divers J, Eberhard L, Gadegbeku CA, Gbadegesin R, Hall ME, Jones-Smith T, Knight R, Kopp JB, Kovesdy CP, Norris KC, Olabisi OA, Roberts GV, Sedor JR, Blacksher E. Diagnosis, Education, and Care of Patients with APOL1-Associated Nephropathy: A Delphi Consensus and Systematic Review. J Am Soc Nephrol 2021:ASN. [PMID: 33853887 DOI: 10.1681/ASN.2020101399] [Reference Citation Analysis]
63 Young BA, Blacksher E, Cavanaugh KL, Freedman BI, Fullerton SM, Kopp JB, Umeukeje EM, West KM, Wilson JG, Burke W; APOL1 Stakeholders Project. Apolipoprotein L1 Testing in African Americans: Involving the Community in Policy Discussions. Am J Nephrol 2019;50:303-11. [PMID: 31480040 DOI: 10.1159/000502675] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]